Schott Pharma AG KGaA (WBO:1SXP) Days Sales Outstanding : 64.78 (As of Dec. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Schott Pharma AG KGaA Days Sales Outstanding?

Schott Pharma AG KGaA's average Accounts Receivable for the three months ended in Dec. 2024 was €163.2 Mil. Schott Pharma AG KGaA's Revenue for the three months ended in Dec. 2024 was €229.8 Mil. Hence, Schott Pharma AG KGaA's Days Sales Outstanding for the three months ended in Dec. 2024 was 64.78.

The historical rank and industry rank for Schott Pharma AG KGaA's Days Sales Outstanding or its related term are showing as below:

WBO:1SXP' s Days Sales Outstanding Range Over the Past 10 Years
Min: 58.68 Med: 62.17 Max: 64.9
Current: 63.18

During the past 5 years, Schott Pharma AG KGaA's highest Days Sales Outstanding was 64.90. The lowest was 58.68. And the median was 62.17.

WBO:1SXP's Days Sales Outstanding is ranked better than
53.87% of 813 companies
in the Medical Devices & Instruments industry
Industry Median: 65.94 vs WBO:1SXP: 63.18

Schott Pharma AG KGaA's Days Sales Outstanding increased from Dec. 2023 (61.60) to Dec. 2024 (64.78).

Schott Pharma AG KGaA Days Sales Outstanding Historical Data

The historical data trend for Schott Pharma AG KGaA's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Schott Pharma AG KGaA Days Sales Outstanding Chart

Schott Pharma AG KGaA Annual Data

Trend

Sep20

Sep21

Sep22

Sep23

Sep24

Days Sales Outstanding

62.17

61.09

58.68

63.35

64.90

Schott Pharma AG KGaA Quarterly Data
	Sep20	Sep21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Days Sales Outstanding	Get a 7-Day Free Trial							61.60	61.96	63.32	68.68	64.78

Competitive Comparison of Schott Pharma AG KGaA's Days Sales Outstanding

For the Medical Instruments & Supplies subindustry, Schott Pharma AG KGaA's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Schott Pharma AG KGaA's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Schott Pharma AG KGaA's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Schott Pharma AG KGaA's Days Sales Outstanding falls into.

Save Embed

;

Save Embed

;

Schott Pharma AG KGaA Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Schott Pharma AG KGaA's Days Sales Outstanding for the fiscal year that ended in Sep. 2024 is calculated as

	Days Sales Outstanding (A: Sep. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Sep. 2024 ))	/	count )	/	Revenue (A: Sep. 2024 )	*	Days in Period
=	( (165.49	+	174.888)	/	2 )	/	957.091	*	365
=	170.189					/	957.091	*	365
=	64.90

Schott Pharma AG KGaA's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

	Days Sales Outstanding (Q: Dec. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2024 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )	/	Revenue (A: Dec. 2024 )	*	Days in Period
=	( (174.888	+	151.43)	/	2 )	/	229.841	*	365 / 4
=	163.159					/	229.841	*	365 / 4
=	64.78

Schott Pharma AG KGaA (WBO:1SXP) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Schott Pharma AG KGaA Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Schott Pharma AG KGaA's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Schott Pharma AG KGaA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Schott Pharma AG & CO KGaA (WBO:1SXP) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

SHTPY:USA 1SXPd:UK 1SXP:Germany

Address

Hattenbergstrasse 10, Mainz, RP, DEU, 55122

Website

https://www.schott-pharma.com

Schott Pharma AG & CO KGaA caters to the pharma, biotech and life science industry by providing containment solutions and delivery systems for injectable drugs. Its segments include; Drug Containment Solutions (DCS) and Drug Delivery Systems (DDS). The majority of the revenue is generated from Drug Containment Solutions segment which includes products like vials, cartridges and ampoules for safe drug containment. Geographically, the company generates revenue from Europe, Middle East, Africa (EMEA), Asia and South Pacific, North America and South America.

Schott Pharma AG KGaA Headlines

No Headlines